Wockhardt inks pact to produce, supply Sputnik vaccine to Dubai-based firm
The Hindu
Subject to requisite approvals and other conditions, the company will manufacture and supply to Enso up to 620 million doses of the Sputnik V and the Sputnik Light vaccines, Wockhardt said.
Drug maker Wockhardt on Friday said it has inked a pact with Dubai-based Enso Healthcare and a subsidiary of Russian Direct Investment Fund (RDIF) for production and supply of vaccine Sputnik. The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC, a wholly owned unit of the management company of RDIF to manufacture and supply Sputnik V, Sputnik Light vaccine against , Wockhardt said in a regulatory filing. Subject to requisite approvals and other conditions, upon successful technology transfer from Human Vaccine LLC, the company will manufacture and supply to Enso up to 620 million doses of the Sputnik V and the Sputnik Light vaccines, it added.More Related News
One dies, eight hospitalised after inhaling HCL fumes at pharma company in Andhra Pradesh’s Anakapalli district. About 400 litres of HCL leaked from the reactor-cum-receiver tank at Unit-III of the company, which affected nine workers, says Collector. While the condition of six of them is stable, two are on ventilator support. Chief Minister Chandrababu Naidu directs authorities to provide advanced treatment to the victims. Home Minister Anitha expresses anger over repeated such incidents.